Soybean Oil Pharma Grade Market 2026-2034 | Size, Share & Trends
Coverage: Soybean Oil Pharma Grade Market covers analysis By Product Type (Refined, bleached, deodorized (RBD) soybean oil, Hydrogenated soybean oil, Fractionated soybean oil); Application (Carrier oil for injectable formulations, Excipient in oral dosage forms (capsules, tablets), Base for topical and dermal delivery systems, Nutraceutical/oil-based supplements); Form (Liquid form, Semi-solid form (e.g., gels, ointment base)); End User (Pharmaceutical manufacturing, Nutraceuticals/dietary supplements, Medical device coatings, Cosmetic/dermatological preparation (pharma grade use)); and Geography
- Report Date : Feb 2026
- Report Code : TIPRE00042216
- Category : Life Sciences
- Status : Upcoming
- Available Report Formats :
- No. of Pages : 150
The soybean oil pharma grade market size is expected to reach US$ 2.46 billion by 2034 from US$ 1.38 billion in 2025. The market is anticipated to register a CAGR of 6.63% during 2026–2034.
Soybean Oil Pharma Grade Market AnalysisThe expansion of the soybean oil pharma grade market is attributable to several structural trends. The growth factor is the pharmaceutical industry's transition to plant-based and naturally sourced excipients. Additionally, manufacturers are replacing synthetic and mineral oils with bio-based oils, which have a more favorable biocompatibility and sustainability profile. Soybean oil aligns well with this trend because it is abundant, renewable, and generally cheaper than other plant-based oils.
Soybean Oil Pharma Grade Market OverviewPharmaceutical-grade soybean oil, or soy oil, is a highly refined and purified form of soybean oil that complies with rigorous pharmaceutical standards. Soy oil is primarily appealing due in large part to its high stability, safety, and biocompatibility, making it a carrier for lipophilic active pharmaceutical ingredients (APIs); an excipient as part of the formulation process, or contributing to oxidative stability in pharmaceutical products.
Strategic Insights
Soybean Oil Pharma Grade Market Drivers and OpportunitiesMarket Drivers:
- Rising Demand for Natural Excipients: The preference for natural, plant-based ingredients is contributing to the use of pharma-grade soybean oil as an effective excipient that is clean label and biocompatible. This grows in light of increasing health consciousness and demand for sustainable, organic pharmaceutical and nutraceutical products globally, which further drives uptake for advanced drug delivery formulations.
- Expansion of Pharmaceutical Manufacturing: Growth in pharmaceutical manufacturing worldwide boosts demand for high-purity excipients like pharma-grade soybean oil. Advanced drug delivery system development, biologics, and nutraceutical production require stable, contaminant-free carrier oils, making soybean oil vital in improving drug stability, bioavailability, and safety.
- Favorable Government Policies and Investments: Supportive government initiatives and investment in pharmaceutical manufacturing and biotechnology, especially in emerging markets like the Asia Pacific, promote local production and use of plant-based excipients, including pharma-grade soybean oil, facilitating market expansion through infrastructure development and R&D support.
Market Opportunities:
- Expansion in Nutraceuticals: Growth in the health and wellness trend across the world will continue to drive demand for natural, clean-label ingredients such as pharma-grade soybean oil in nutraceutical formulations, predominantly soft gel capsules and dietary supplements. Its biocompatibility and high purity make it a suitable carrier for fat-soluble vitamins, thereby presenting greater growth opportunities.
- Technological Integration: Improvements in refining technology and the application of artificial intelligence open up new pathways for enhanced product quality, process improvements, and cost savings. The AI-enhanced improvement of traceability and predictive maintenance supports production in meeting rigorous pharmaceutical standards while continually enhancing competitiveness.
- Emerging Markets Growth: Rapid pharmaceutical and nutraceutical industry growth in emerging markets like the Asia Pacific provides significant opportunities. Expanding healthcare infrastructure, rising disposable incomes, and government support for local production encourage increasing pharmaceutical-grade soybean oil consumption.
The soybean oil pharma grade market share is analyzed across various segments to provide a clearer understanding of its structure, growth potential, and emerging trends. Below is the standard segmentation approach used in most industry reports:
By Product Type:
-
Refined, bleached, deodorized (RBD) soybean oil: Highly purified and highly stable oil, which is commonly used as a safe carrier and excipient in both topical and systemic pharmaceutical formulations and injectables.
-
Hydrogenated soybean oil: Processed to improve oxidative stability and texture, suitable for semi-solid dosage forms, creams, and ointment bases in pharmaceuticals.
-
Fractionated soybean oil: Fractionated oil has specific triglyceride fractions for improved purity and performance, especially in parenteral nutrition or modern drug delivery systems.
By Application:
-
Carrier oil for injectable formulations: Provides a lipid environment for parenteral nutrition and intravenous emulsions while also ensuring stability for drugs within injectable formulations.
-
Excipient in oral dosage forms (capsules, tablets): Acts as a solubilizer and lubricant to improve drug bioavailability and uniformity in the capsule and tablet oral formulations.
-
Base for topical and dermal delivery systems: Provides emollient properties, aiding in easy application and penetration within dermatological and cosmeceutical formulations.
-
Nutraceutical/oil-based supplements: Carries fat-soluble vitamins and omega supplements, while providing stability for formulations, and enhances the bioavailability of nutrients.
By Form:
- Liquid form: Used in injectables, emulsions, and softgel formulations for its smooth flow, stability, and compatibility with lipid-based systems.
- Semi-solid form (e.g., gels, ointment base): Employed in topical preparations and creams for controlled release, moisturizing effect, and enhanced skin penetration.
By End User:
- Pharmaceutical manufacturing
- Nutraceuticals/dietary supplements
- Medical device coatings
- Cosmetic/dermatological preparation (pharma grade use)
By Geography:
- North America
- Europe
- Asia-Pacific
- South & Central America
- Middle East & Africa
Market Report Scope
Soybean Oil Pharma Grade Market Share Analysis by GeographyNorth America led the global market with the highest share of 30% in 2024, spurred by its highly advanced and well-established pharmaceutical industry, health care infrastructure, as well as strong regulatory system. Asia Pacific is estimated to grow at the fastest CAGR during the forecast period. The increasing demand for natural and plant-based ingredients in healthcare products is increased awareness of better health, better living standards, and the increase in disposable income.
The soybean oil pharma grade market shows a different growth trajectory in each region due to factors such as rising health awareness and preventive healthcare trends. Below is a summary of market share and trends by region:
1. North America
- Market Share: Holds the highest market share, driven by the U.S. pharmaceutical industry's size and maturity.
- Key Drivers: The region's advanced pharmaceutical and biotech R&D ecosystem, stringent regulatory framework, high consumer health awareness, and domestic soybean farming contribute to steady market expansion.
- Trends: North America trends include the adoption of advanced refining technologies, sustainable sourcing practices, integration of artificial intelligence for process optimization, and increased use of pharma-grade soybean oil in biologics and injectable formulations.
2. Europe
- Market Share: Europe holds a stable share due to well-established pharmaceutical industries and mature regulatory bodies.
- Key Drivers: Demand is driven by increasing interest in sustainable, clean-label pharmaceutical ingredients and technological innovation in plant-based excipients.
- Trends: Growth in eco-friendly and green manufacturing practices, focus on regulatory compliance, and product diversification into cosmetic and nutraceutical sectors are notable trends.
3. Asia Pacific
- Market Share: Asia Pacific is the fastest-growing region with rapid expansion in pharmaceutical manufacturing and nutraceutical consumption.
- Key Drivers: Increased healthcare infrastructure investments, rising disposable income, government initiatives promoting local pharmaceutical production, and growing health consciousness drive adoption.
- Trends: Emphasis on partnerships between local and global manufacturers, rising demand for natural and plant-based ingredients, adoption of modern refining techniques, and increasing use in soft gel capsules and nutraceuticals characterize the market.
4. South and Central America
- Market Share: These regions represent emerging markets with smaller current shares but steady growth potential.
- Key Drivers: Expanding healthcare infrastructure, government support for pharmaceutical sector growth, and rising disease prevalence contribute to increasing demand.
- Trends: Improving regulatory frameworks, increasing foreign direct investments, and growing consumer awareness about natural and plant-based ingredients are shaping market dynamics.
5. Middle East and Africa
- Market Share: Emerging markets are increasing pharmaceutical manufacturing activities and healthcare investments.
- Key Drivers: Expanding healthcare infrastructure, rising prevalence of chronic diseases, growing consumer awareness of natural, plant-based pharmaceutical ingredients, and government initiatives aimed at strengthening local pharmaceutical and nutraceutical sectors.
- Trends: Improving regulatory frameworks to meet pharmaceutical-grade standards, adoption of sustainable and clean-label ingredients, and gradual infrastructure development in pharmaceutical production.
The soybean oil pharma grade market is witnessing intensified competition due to the presence of major global technology providers alongside emerging niche players and specialized startups. Companies are actively innovating to strengthen their market position and meet the growing demand for intelligent decision-making platforms across industries.
The competitive landscape is driving vendors to differentiate through:
- Manufacturers are heavily investing in refining, bleaching, deodorizing, and chemical control to comply with stringent pharmacopeial standards (USP, EP, IP) for excipients.
- Sustainable sourcing and green manufacturing meet consumer demand for environmentally responsible soy oil products for pharma-grade applications.
- Adoption of AI technologies and automation improves production, shortens production times, improves quality control, improves supply chain transparency, reduces costs, and consistent and reliable products.
Opportunities and Strategic Moves
- Collaborations and partnerships with pharmaceutical companies and research institutions help accelerate innovation and expand product applications.
- Increasing health awareness and the preference for organic, clean-label products drive growth.
- Investing in advanced refining and purification technologies to enhance oil quality and consistency, meeting stringent regulatory standards.
- Archer Daniels Midland Company (ADM)- United States
- Cargill Inc- United States
- Bunge Limited- Netherlands
- Guangzhou Hanfang Pharmaceutical Co., Ltd- China
- Zhejiang Tianyushan Medicinal Oil Co., Ltd- China
- Xinxing Pharma (Yaopharma)- China
- Xian Tianzheng Medicinal Materials Co., Ltd.- China
- Wilmar International Limited - Singapore
Disclaimer: The companies listed above are not ranked in any particular order.
Soybean Oil Pharma Grade Market News and Recent Developments- For instance, on August 29, 2025, ADM announced that it is taking moves to streamline and strengthen its global soy protein production network. This will improve efficiency and help it better serve customers around the world by capitalizing on the benefits of operational leverage and excellence at its recently recommissioned soy protein facility in Decatur, Illinois, as well as other facilities spanning its global network.
- In August 2024, Farmers Business Network and ADM announced they had created a joint-venture company, called Gradable, through which they would expand the Gradable technology platform to allow more farmers and buyers to confidently pursue and derive value from grain produced using sustainable and regenerative practices.
- In February 2023, Bunge announced it had achieved 80% traceability and monitoring of soybeans from its indirect supply chain in the Brazilian Cerrado. The pioneering, large-scale initiative for tracking indirect purchases in the biome is part of Bunge's Sustainable Partnership Program and underscores consistent performance by the company in the development of sustainable and responsible supply chains, especially in those areas at higher risk of deforestation in Brazil.
The "Soybean Oil Pharma Grade Market Size and Forecast (2021–2034)" report provides a detailed analysis of the market covering below areas:
- Soybean Oil Pharma Grade Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Soybean Oil Pharma Grade Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Soybean Oil Pharma Grade Market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments in the Soybean Oil Pharma Grade Market. Detailed company profiles
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
North America leads due to advanced pharmaceutical infrastructure, with Asia Pacific as the fastest-growing market, fueled by expanding pharma manufacturing and rising health awareness.
Challenges include raw material price volatility due to fluctuating soybean crop yields and stringent regulatory compliance requirements for pharmaceutical applications.
Integration of AI in refining processes, demand for clean-label products, innovation in drug delivery systems, and regional expansion into emerging markets are key trends.
Rising demand for plant-based, natural ingredients, increasing pharmaceutical and nutraceutical production, and advancements in refining technologies drive market growth.
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For